Target intelligence / Profile preview

Hepatitis B virus X and S open reading frame RNA transcripts (HBV X/S RNA)

Target
HBV X/S RNA
Molecular classification
Viral RNA, Messenger RNA
01

Overview

Hepatitis B virus (HBV) X and S open reading frame RNA transcripts are essential viral messenger RNAs produced during the HBV life cycle (Source: PubMed, PMID: 32635331). These transcripts encode the Hepatitis B surface antigen (HBsAg), which is vital for viral entry and immune evasion, and the X protein (HBx), which is necessary for the initiation and maintenance of viral transcription from covalently closed circular DNA (cccDNA) (Source: UniProt, P03138). Due to the overlapping nature of the HBV genome, the X and S regions are present in nearly all viral RNA species, including the pregenomic RNA (pgRNA). This makes them an ideal target for sequence-specific therapies such as RNA interference (RNAi) and antisense oligonucleotides (ASOs) (Source: NIH, ClinicalTrials.gov). By degrading these transcripts, these drugs can significantly reduce the production of all viral proteins and pregenomic RNA, potentially reversing the immune exhaustion caused by high levels of circulating HBsAg and facilitating a functional cure for chronic hepatitis B (Source: Journal of Hepatology, 2021).

Other names
HBV mRNAHepatitis B virus transcriptsHBV X-S overlapping region RNAHBV pregenomic and subgenomic RNA
02

Mechanism of action

Degradation of viral RNA transcripts via RNA interference (RNAi) or RNase H-mediated antisense oligonucleotide (ASO) activity, leading to reduced viral protein production and inhibition of replication.

03

Biological functions

Viral replicationProtein translationImmune evasioncccDNA transcriptional regulation
04

Disease associations

Chronic Hepatitis BHepatocellular carcinomaLiver cirrhosis
05

Safety considerations

Therapeutic ALT flaresImmune-mediated hepatotoxicityOff-target RNA degradationPotential for viral rebound upon treatment cessation
06

Interacting drugs

JNJ-3989

4 more in the full profile.

07

Biomarkers

HBsAg levelsSerum HBV RNAHBV DNAHBcrAgALT levels

Beyond the preview

Go deeper on Hepatitis B virus X and S open reading frame RNA transcripts (HBV X/S RNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis B virus X and S open reading frame RNA transcripts (HBV X/S RNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call